{"pmid":32324118,"title":"Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","text":["Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment.","Emerg Infect Dis","Adams, Mary L","Katz, David L","Grandpre, Joseph","32324118"],"abstract":["We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment."],"journal":"Emerg Infect Dis","authors":["Adams, Mary L","Katz, David L","Grandpre, Joseph"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324118","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200679","keywords":["covid-19","sars-cov-2","united states","chronic conditions","complications","coronavirus disease","infection","population-based estimates","respiratory infections","risk factors","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["US","Coronavirus Disease","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664895932847620096,"score":8.518259,"similar":[{"pmid":32315282,"title":"Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","text":["Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered.","Emerg Infect Dis","Ge, Yang","Sun, Shengzhi","32315282"],"abstract":["We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered."],"journal":"Emerg Infect Dis","authors":["Ge, Yang","Sun, Shengzhi"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315282","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.201093","keywords":["2019 novel coronavirus disease","covid-19","sars","sars-cov-2","coronavirus","coronavirus disease","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"_version_":1664714520204935168,"score":154.02171},{"pmid":32160149,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures.","Emerg Infect Dis","Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J","32160149"],"abstract":["The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures."],"journal":"Emerg Infect Dis","authors":["Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160149","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200516","keywords":["2019 novel coronavirus disease","covid-19","pcr","sars-cov-2","united states","characterization","coronavirus","isolation","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["Wuhan","China","United States","Washington","United States"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"_version_":1664640874800218113,"score":149.22351},{"pmid":32168464,"title":"Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","text":["Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.","Emerg Infect Dis","Mizumoto, Kenji","Chowell, Gerardo","32168464"],"abstract":["Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control."],"journal":"Emerg Infect Dis","authors":["Mizumoto, Kenji","Chowell, Gerardo"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168464","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200233","keywords":["2019 novel coronavirus disease","cfr","covid-19","china","hubei","sars-cov-2","wuhan","case-fatality ratio","coronavirus","death","mortality","outbreak","respiratory diseases","risk","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting","Prevention"],"weight":1,"locations":["Wuhan","China","China","Wuhan","China","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874724720640,"score":123.9841},{"pmid":32330410,"title":"Doubling Time of the COVID-19 Epidemic by Province, China.","text":["Doubling Time of the COVID-19 Epidemic by Province, China.","In China, the doubling time of the coronavirus disease epidemic by province increased during January 20-February 9, 2020. Doubling time estimates ranged from 1.4 (95% CI 1.2-2.0) days for Hunan Province to 3.1 (95% CI 2.1-4.8) days for Xinjiang Province. The estimate for Hubei Province was 2.5 (95% CI 2.4-2.6) days.","Emerg Infect Dis","Muniz-Rodriguez, Kamalich","Chowell, Gerardo","Cheung, Chi-Hin","Jia, Dongyu","Lai, Po-Ying","Lee, Yiseul","Liu, Manyun","Ofori, Sylvia K","Roosa, Kimberlyn M","Simonsen, Lone","Viboud, Cecile","Fung, Isaac Chun-Hai","32330410"],"abstract":["In China, the doubling time of the coronavirus disease epidemic by province increased during January 20-February 9, 2020. Doubling time estimates ranged from 1.4 (95% CI 1.2-2.0) days for Hunan Province to 3.1 (95% CI 2.1-4.8) days for Xinjiang Province. The estimate for Hubei Province was 2.5 (95% CI 2.4-2.6) days."],"journal":"Emerg Infect Dis","authors":["Muniz-Rodriguez, Kamalich","Chowell, Gerardo","Cheung, Chi-Hin","Jia, Dongyu","Lai, Po-Ying","Lee, Yiseul","Liu, Manyun","Ofori, Sylvia K","Roosa, Kimberlyn M","Simonsen, Lone","Viboud, Cecile","Fung, Isaac Chun-Hai"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330410","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200219","keywords":["2019 novel coronavirus disease","covid-19","china","sars-cov-2","coronavirus","epidemiology","infectious disease transmission","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"locations":["China","Hunan","Xinjiang","Hubei","Province","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664996914837323777,"score":123.24024},{"pmid":32298984,"pmcid":"PMC7146694","title":"Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis.","text":["Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis.","INTRODUCTION: and aims: To prevent the spread of coronavirus disease (COVID19) total lockdown is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the impact of the duration of the lockdown on glycaemic control and diabetes-related complications. MATERIALS AND METHODS: A systematic search was conducted using Cochrane library. A simulation model was created using glycemic data from previous disasters (taken as similar in impact to current lockdown) taking baseline HBA1c and diabetes-related complications data from India-specific database. A multivariate regression analysis was conducted to analyse the relationship between the duration of lockdown and glycaemic targets & diabetes-related complications. RESULTS: The predictive model was extremely robust (R2 = 0.99) and predicted outcomes for period of lockdown up to 90 days. The predicted increment in HBA1c from baseline at the end of 30 days and 45 days lockdown was projected as 2.26% & 3.68% respectively. Similarly, the annual predicted percentage increase in complication rates at the end of 30-day lockdown was 2.8% for non-proliferative diabetic retinopathy, 2.9% for proliferative diabetic retinopathy, 1.5% for retinal photocoagulation, 9.3% for microalbuminuria, 14.2% for proteinuria, 2.9% for peripheral neuropathy, 10.5% for lower extremity amputation, 0.9% for myocardial infarction, 0.5% for stroke and 0.5% for infections. CONCLUSION: The duration of lockdown is directly proportional to the worsening of glycaemic control and diabetes-related complications. Such increase in diabetes-related complications will put additional load on overburdened healthcare system, and also increase COVID19 infections in patients with such uncontrolled glycemia.","Diabetes Metab Syndr","Ghosal, Samit","Sinha, Binayak","Majumder, Milan","Misra, Anoop","32298984"],"abstract":["INTRODUCTION: and aims: To prevent the spread of coronavirus disease (COVID19) total lockdown is in place in India from March 24, 2020 for 21 days. In this study, we aim to assess the impact of the duration of the lockdown on glycaemic control and diabetes-related complications. MATERIALS AND METHODS: A systematic search was conducted using Cochrane library. A simulation model was created using glycemic data from previous disasters (taken as similar in impact to current lockdown) taking baseline HBA1c and diabetes-related complications data from India-specific database. A multivariate regression analysis was conducted to analyse the relationship between the duration of lockdown and glycaemic targets & diabetes-related complications. RESULTS: The predictive model was extremely robust (R2 = 0.99) and predicted outcomes for period of lockdown up to 90 days. The predicted increment in HBA1c from baseline at the end of 30 days and 45 days lockdown was projected as 2.26% & 3.68% respectively. Similarly, the annual predicted percentage increase in complication rates at the end of 30-day lockdown was 2.8% for non-proliferative diabetic retinopathy, 2.9% for proliferative diabetic retinopathy, 1.5% for retinal photocoagulation, 9.3% for microalbuminuria, 14.2% for proteinuria, 2.9% for peripheral neuropathy, 10.5% for lower extremity amputation, 0.9% for myocardial infarction, 0.5% for stroke and 0.5% for infections. CONCLUSION: The duration of lockdown is directly proportional to the worsening of glycaemic control and diabetes-related complications. Such increase in diabetes-related complications will put additional load on overburdened healthcare system, and also increase COVID19 infections in patients with such uncontrolled glycemia."],"journal":"Diabetes Metab Syndr","authors":["Ghosal, Samit","Sinha, Binayak","Majumder, Milan","Misra, Anoop"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298984","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.dsx.2020.03.014","keywords":["complications","diabetes","disaster","lockdown","multivariate regression analysis"],"source":"PubMed","topics":["Epidemic Forecasting","Prevention"],"weight":1,"locations":["India","India","microalbuminuria"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664641388444123137,"score":122.97856}]}